BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 22201888)

  • 1. Activation of Wnt and Myc signaling in hepatoblastoma.
    Cairo S; Armengol C; Buendia MA
    Front Biosci (Elite Ed); 2012 Jan; 4(1):480-6. PubMed ID: 22201888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic stem-like phenotype and interplay of Wnt/beta-catenin and Myc signaling in aggressive childhood liver cancer.
    Cairo S; Armengol C; De Reyniès A; Wei Y; Thomas E; Renard CA; Goga A; Balakrishnan A; Semeraro M; Gresh L; Pontoglio M; Strick-Marchand H; Levillayer F; Nouet Y; Rickman D; Gauthier F; Branchereau S; Brugières L; Laithier V; Bouvier R; Boman F; Basso G; Michiels JF; Hofman P; Arbez-Gindre F; Jouan H; Rousselet-Chapeau MC; Berrebi D; Marcellin L; Plenat F; Zachar D; Joubert M; Selves J; Pasquier D; Bioulac-Sage P; Grotzer M; Childs M; Fabre M; Buendia MA
    Cancer Cell; 2008 Dec; 14(6):471-84. PubMed ID: 19061838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of SFRP1 is a protumorigenic event in hepatoblastoma and correlates with beta-catenin mutations.
    Regel I; Eichenmüller M; Mahajan UM; Hagl B; Benitz S; Häberle B; Vokuhl C; von Schweinitz D; Kappler R
    J Cancer Res Clin Oncol; 2020 May; 146(5):1153-1167. PubMed ID: 32189106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wnt signaling and hepatocarcinogenesis: the hepatoblastoma model.
    Armengol C; Cairo S; Fabre M; Buendia MA
    Int J Biochem Cell Biol; 2011 Feb; 43(2):265-70. PubMed ID: 19646548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated expression of Wnt antagonists is a common event in hepatoblastomas.
    Koch A; Waha A; Hartmann W; Hrychyk A; Schüller U; Waha A; Wharton KA; Fuchs SY; von Schweinitz D; Pietsch T
    Clin Cancer Res; 2005 Jun; 11(12):4295-304. PubMed ID: 15958610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutant
    Crippa S; Ancey PB; Vazquez J; Angelino P; Rougemont AL; Guettier C; Zoete V; Delorenzi M; Michielin O; Meylan E
    EMBO Mol Med; 2017 Nov; 9(11):1589-1604. PubMed ID: 28923827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. beta-Catenin and met deregulation in childhood Hepatoblastomas.
    Ranganathan S; Tan X; Monga SP
    Pediatr Dev Pathol; 2005; 8(4):435-47. PubMed ID: 16211454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HGF/c-Met related activation of β-catenin in hepatoblastoma.
    Purcell R; Childs M; Maibach R; Miles C; Turner C; Zimmermann A; Sullivan M
    J Exp Clin Cancer Res; 2011 Oct; 30(1):96. PubMed ID: 21992464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of β-catenin and Yap1 in human hepatoblastoma and induction of hepatocarcinogenesis in mice.
    Tao J; Calvisi DF; Ranganathan S; Cigliano A; Zhou L; Singh S; Jiang L; Fan B; Terracciano L; Armeanu-Ebinger S; Ribback S; Dombrowski F; Evert M; Chen X; Monga SPS
    Gastroenterology; 2014 Sep; 147(3):690-701. PubMed ID: 24837480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coordinated Activities of Multiple Myc-dependent and Myc-independent Biosynthetic Pathways in Hepatoblastoma.
    Wang H; Lu J; Edmunds LR; Kulkarni S; Dolezal J; Tao J; Ranganathan S; Jackson L; Fromherz M; Beer-Stolz D; Uppala R; Bharathi S; Monga SP; Goetzman ES; Prochownik EV
    J Biol Chem; 2016 Dec; 291(51):26241-26251. PubMed ID: 27738108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GREB1 induced by Wnt signaling promotes development of hepatoblastoma by suppressing TGFβ signaling.
    Matsumoto S; Yamamichi T; Shinzawa K; Kasahara Y; Nojima S; Kodama T; Obika S; Takehara T; Morii E; Okuyama H; Kikuchi A
    Nat Commun; 2019 Aug; 10(1):3882. PubMed ID: 31462641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exome sequencing of hepatoblastoma reveals novel mutations and cancer genes in the Wnt pathway and ubiquitin ligase complex.
    Jia D; Dong R; Jing Y; Xu D; Wang Q; Chen L; Li Q; Huang Y; Zhang Y; Zhang Z; Liu L; Zheng S; Xia Q; Wang H; Dong K; He X
    Hepatology; 2014 Nov; 60(5):1686-96. PubMed ID: 24912477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications.
    Carrillo-Reixach J; Torrens L; Simon-Coma M; Royo L; Domingo-Sàbat M; Abril-Fornaguera J; Akers N; Sala M; Ragull S; Arnal M; Villalmanzo N; Cairo S; Villanueva A; Kappler R; Garrido M; Guerra L; Sábado C; Guillén G; Mallo M; Piñeyro D; Vázquez-Vitali M; Kuchuk O; Mateos ME; Ramírez G; Santamaría ML; Mozo Y; Soriano A; Grotzer M; Branchereau S; de Andoin NG; López-Ibor B; López-Almaraz R; Salinas JA; Torres B; Hernández F; Uriz JJ; Fabre M; Blanco J; Paris C; Bajčiová V; Laureys G; Masnou H; Clos A; Belendez C; Guettier C; Sumoy L; Planas R; Jordà M; Nonell L; Czauderna P; Morland B; Sia D; Losic B; Buendia MA; Sarrias MR; Llovet JM; Armengol C
    J Hepatol; 2020 Aug; 73(2):328-341. PubMed ID: 32240714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diminished WNT -> β-catenin -> c-MYC signaling is a barrier for malignant progression of BRAFV600E-induced lung tumors.
    Juan J; Muraguchi T; Iezza G; Sears RC; McMahon M
    Genes Dev; 2014 Mar; 28(6):561-75. PubMed ID: 24589553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CITED1 expression in liver development and hepatoblastoma.
    Murphy AJ; de Caestecker C; Pierce J; Boyle SC; Ayers GD; Zhao Z; Libes JM; Correa H; Walter T; Huppert SS; Perantoni AO; de Caestecker MP; Lovvorn HN
    Neoplasia; 2012 Dec; 14(12):1153-63. PubMed ID: 23308048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β-Catenin mutations as determinants of hepatoblastoma phenotypes in mice.
    Zhang W; Meyfeldt J; Wang H; Kulkarni S; Lu J; Mandel JA; Marburger B; Liu Y; Gorka JE; Ranganathan S; Prochownik EV
    J Biol Chem; 2019 Nov; 294(46):17524-17542. PubMed ID: 31597698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Advances in Understanding of Molecular Pathogenesis of Hepatoblastoma: A Wnt/β-Catenin Perspective.
    Bell D; Ranganathan S; Tao J; Monga SP
    Gene Expr; 2017 Feb; 17(2):141-154. PubMed ID: 27938502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Hippo Effector Transcriptional Coactivator with PDZ-Binding Motif Cooperates with Oncogenic β-Catenin to Induce Hepatoblastoma Development in Mice and Humans.
    Zhang S; Zhang J; Evert K; Li X; Liu P; Kiss A; Schaff Z; Ament C; Zhang Y; Serra M; Evert M; Chen N; Xu F; Chen X; Tao J; Calvisi DF; Cigliano A
    Am J Pathol; 2020 Jul; 190(7):1397-1413. PubMed ID: 32283103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute overexpression of Myc in intestinal epithelium recapitulates some but not all the changes elicited by Wnt/beta-catenin pathway activation.
    Finch AJ; Soucek L; Junttila MR; Swigart LB; Evan GI
    Mol Cell Biol; 2009 Oct; 29(19):5306-15. PubMed ID: 19635809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel tissue-based ß-catenin gene and immunohistochemical analysis to exclude familial adenomatous polyposis among children with hepatoblastoma tumors.
    Dubbink HJ; Hollink IHIM; Avenca Valente C; Wang W; Liu P; Doukas M; van Noesel MM; Dinjens WNM; Wagner A; Smits R
    Pediatr Blood Cancer; 2018 Jun; 65(6):e26991. PubMed ID: 29446530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.